ABTB1 modulates EGFR signaling and confers icotinib sensitivity in lung adenocarcinoma.

Li SY, Xia L, Xu P, Li GH, Yang BC, Wu JX, Zhang FX, Lian JB

Open source

DOI
10.1186/s12931-026-03682-7
Published
2026 Apr 27
Container
Respiratory research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12931-026-03682-7,
  title = {ABTB1 modulates EGFR signaling and confers icotinib sensitivity in lung adenocarcinoma.},
  author = {Li SY and Xia L and Xu P and Li GH and Yang BC and Wu JX and Zhang FX and Lian JB},
  year = {2026},
  journal = {Respiratory research},
  doi = {10.1186/s12931-026-03682-7},
  url = {https://doi.org/10.1186/s12931-026-03682-7}
}

RIS

TY  - JOUR
TI  - ABTB1 modulates EGFR signaling and confers icotinib sensitivity in lung adenocarcinoma.
AU  - Li SY
AU  - Xia L
AU  - Xu P
AU  - Li GH
AU  - Yang BC
AU  - Wu JX
AU  - Zhang FX
AU  - Lian JB
PY  - 2026
JO  - Respiratory research
DO  - 10.1186/s12931-026-03682-7
UR  - https://doi.org/10.1186/s12931-026-03682-7
ER  - 

APA

SY, L., L, X., P, X., GH, L., BC, Y., JX, W., FX, Z., & JB, L. (2026). ABTB1 modulates EGFR signaling and confers icotinib sensitivity in lung adenocarcinoma.. Respiratory research. https://doi.org/10.1186/s12931-026-03682-7

Source records